Page last updated: 2024-10-24

chlorambucil and Carcinoma 256, Walker

chlorambucil has been researched along with Carcinoma 256, Walker in 33 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Chlorambucil is an exception."1.26Structure-activity relationships in antitumor aniline mustards. ( Hansch, C; Leo, A; Panthananickal, A, 1978)
"Indomethacin alone acts as a growth inhibitor of the Walker carcinoma."1.26Effect of chlorambucil and indomethacin on growth and prostaglandin levels in sensitive and resistant Walker carcinoma. ( Dobrzanski, RJ; Gibbs, J; Tisdale, MJ, 1982)

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-199031 (93.94)18.7374
1990's2 (6.06)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loeffler, LJ2
Sajadi, Z2
Hall, IH2
Panthananickal, A1
Hansch, C1
Leo, A1
Tew, KD6
Moy, BC1
Hartley-Asp, B1
Tisdale, MJ7
Gibbs, J1
Dobrzanski, RJ1
Ramirez, ML1
Shepherd, CR1
Pinsky, SD1
McGhee, KG1
Abel, G1
Harrap, KR1
Powles, TJ2
Frank, GJ1
Millar, JL2
McLean, A1
Newell, D1
Baker, G1
Connors, T1
Clapper, ML3
Kuzmich, S1
Seestaller, LM1
Phillips, BJ6
Srinivasan, SK1
Gupta, VS1
Howarth, RE1
Ford, JM1
Hait, WN1
Matlin, SA1
Benz, CC1
Grunicke, H2
Doppler, W2
Hofmann, J2
Lindner, H1
Maly, K2
Oberhuber, H1
Ringsdorf, H1
Roberts, JJ1
Helliger, W1
Hermann, BJ1
Höck, W1
Puschendorf, B1
Bomber, AM1
Hoffman, SJ1
Kanemura, M1
Ohsawa, N1
Yamazaki, Z1
Greig, NH1
Sweeney, DJ1
Rapoport, SI1
Buller, AL1
Wang, AL1
Mills, FH1
Connors, TA2
Sladek, NE1
Rosenoer, VM1
Mitchley, BC1
Roe, FJ1
Karaivanova, MKh1
Elson, LA1

Reviews

2 reviews available for chlorambucil and Carcinoma 256, Walker

ArticleYear
[Tumor-oriented anti-cancer agent with estrogen as a carrier].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 2-1

    Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chlorambucil; Drug Carriers; Estradiol; Estra

1988
Alkylating agents.
    Topics in current chemistry, 1974, Volume: 52

    Topics: Alkylating Agents; Animals; Biological Transport; Carcinoma 256, Walker; Chlorambucil; Cisplatin; Cy

1974

Other Studies

31 other studies available for chlorambucil and Carcinoma 256, Walker

ArticleYear
Antineoplastic agents. 1. N-Protected vinyl, 1,2-dihaloethyl, and cyanomethyl esters of phenylalanine.
    Journal of medicinal chemistry, 1977, Volume: 20, Issue:12

    Topics: Acetonitriles; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Leth

1977
Antineoplastic agents. 2. Structure-activity studies on N-protected vinyl, 1,2-dibromoethyl, and cyanomethyl esters of several amino acids.
    Journal of medicinal chemistry, 1977, Volume: 20, Issue:12

    Topics: Acetonitriles; Amino Acids; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Ehrlic

1977
Structure-activity relationships in antitumor aniline mustards.
    Journal of medicinal chemistry, 1978, Volume: 21, Issue:1

    Topics: Aniline Mustard; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Hydrolysis; Lethal Dose 50;

1978
Acquired drug resistance is accompanied by modification in the karyotype and nuclear matrix of a rat carcinoma cell line.
    Experimental cell research, 1983, Volume: 149, Issue:2

    Topics: Animals; Carcinoma 256, Walker; Cell Line; Cell Nucleus; Chlorambucil; Chromosome Aberrations; Chrom

1983
Effect of chlorambucil and indomethacin on growth and prostaglandin levels in sensitive and resistant Walker carcinoma.
    Chemico-biological interactions, 1982, Mar-15, Volume: 39, Issue:2

    Topics: Animals; Carcinoma 256, Walker; Cell Division; Chlorambucil; Dinoprostone; Dose-Response Relationshi

1982
Chlorambucil-induced changes in chromatin methylation and their modulation by sodium butyrate.
    Biochemical and biophysical research communications, 1982, Oct-29, Volume: 108, Issue:4

    Topics: Animals; Butyrates; Butyric Acid; Carcinoma 256, Walker; Chlorambucil; Chromatin; Chromosomal Protei

1982
Interactions of cytotoxic and anti-inflammatory agents on normal and neoplastic tissue.
    Advances in prostaglandin and thromboxane research, 1980, Volume: 6

    Topics: Animals; Carcinoma 256, Walker; Cell Survival; Chlorambucil; Flurbiprofen; Hematopoietic Stem Cells;

1980
The metabolism of chlorambucil.
    Biochemical pharmacology, 1980, Jul-15, Volume: 29, Issue:14

    Topics: Animals; Antineoplastic Agents; Biotransformation; Carcinoma 256, Walker; Chlorambucil; In Vitro Tec

1980
Time course of glutathione S-transferase elevation in Walker mammary carcinoma cells following chlorambucil exposure.
    Biochemical pharmacology, 1993, Feb-09, Volume: 45, Issue:3

    Topics: Animals; Carcinoma 256, Walker; Chlorambucil; Drug Resistance; Enzyme Activation; Glutathione Transf

1993
Alterations in adenosine 3', 5'-monophosphate-binding protein in Walker carcinoma cells sensitive or resistant to alkylating agents.
    Biochemical pharmacology, 1976, Aug-15, Volume: 25, Issue:16

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alkylating Agents; Animals; Aziridines; Carcinoma 256, Walker;

1976
Adenosine 3',5'-monophosphate phosphodiesterase activity in experimental animal tumours which are either sensitive or resistant to bifunctional alkylating agents.
    Biochemical pharmacology, 1975, Jan-15, Volume: 24, Issue:2

    Topics: Alkylating Agents; Animals; Carcinoma 256, Walker; Cells, Cultured; Chlorambucil; Cyclic AMP; Drug R

1975
Inhibition of cyclic 3',5'-nucleotide phosphodiesterase-a possible mechanism of action of bifunctional alkylating agents.
    Biochemical pharmacology, 1975, Jan-15, Volume: 24, Issue:2

    Topics: Alkylating Agents; Aminophylline; Animals; Carcinoma 256, Walker; Cattle; Cells, Cultured; Chlorambu

1975
Comparative effects of alkylating agents and other anti-tumour agents on the intracellular level of adenosine 3',5'-monophosphate in Walker carcinoma.
    Biochemical pharmacology, 1975, Jul-15, Volume: 24, Issue:13-14

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alkylating Agents; Animals; Bone Marrow; Carcinoma 256, Walker;

1975
The effect of alkylating agents on the activity of adenosine 3',5'-monophosphate-dependent protein kinase in Walker carcinoma cells.
    Biochemical pharmacology, 1976, Nov-01, Volume: 25, Issue:21

    Topics: Alkylating Agents; Animals; Aziridines; Bucladesine; Carcinoma 256, Walker; Cell Line; Cells, Cultur

1976
Guanosine 3',5'-monophosphate and the action of alkylating agents.
    Chemico-biological interactions, 1977, Volume: 19, Issue:3

    Topics: Alkylating Agents; Animals; Aziridines; Azirines; Carcinoma 256, Walker; Cells, Cultured; Chlorambuc

1977
Non-steroidal anti-inflammatory drugs and cytotoxics.
    Cancer treatment reviews, 1979, Volume: 6 Suppl

    Topics: Animals; Bone Marrow; Carcinoma 256, Walker; Chlorambucil; Digestive System; Flurbiprofen; Indometha

1979
Inhibition of thymidylate synthetase of Walker carcinoma by chlorambucil. A possible mechanism of action.
    Biochemical pharmacology, 1977, Jun-01, Volume: 26, Issue:11

    Topics: Animals; Carcinoma 256, Walker; Cell-Free System; Chlorambucil; Drug Administration Schedule; Drug R

1977
Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers.
    Cancer letters, 1991, Volume: 56, Issue:1

    Topics: Alkylating Agents; Animals; Breast Neoplasms; Buthionine Sulfoximine; Carcinoma 256, Walker; Carmust

1991
Identification of a glutathione S-transferase associated with microsomes of tumor cells resistant to nitrogen mustards.
    Biochemical pharmacology, 1989, Jun-15, Volume: 38, Issue:12

    Topics: Animals; Blotting, Western; Carcinoma 256, Walker; Cell Survival; Chlorambucil; Cytosol; Drug Resist

1989
Plasma membrane as target of alkylating agents.
    Advances in enzyme regulation, 1985, Volume: 24

    Topics: Adenosine Triphosphatases; Alkylating Agents; Animals; Calcium Channel Blockers; Carcinoma 256, Walk

1985
Differential sensitivity of histone acetylation in nitrogen-mustard sensitive and resistant cells. Relation to drug uptake, formation and repair of DNA-interstrand cross-links.
    European journal of cancer & clinical oncology, 1988, Volume: 24, Issue:12

    Topics: Acetylation; Animals; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Chlorambucil; Cyclophosphamid

1988
Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines.
    Cancer research, 1988, Jul-01, Volume: 48, Issue:13

    Topics: Animals; Carcinoma 256, Walker; Cell Survival; Chlorambucil; Drug Resistance; Drug Synergism; Epopro

1988
[An experimental study of cancer therapy through the augmented foreign body reaction].
    Nihon Gan Chiryo Gakkai shi, 1988, Jan-20, Volume: 23, Issue:1

    Topics: Animals; Carcinoma 256, Walker; Chlorambucil; Estradiol; Foreign-Body Reaction; Rats; Rats, Inbred S

1988
Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.
    Cancer chemotherapy and pharmacology, 1988, Volume: 21, Issue:1

    Topics: Amino Acids; Animals; Blood Proteins; Brain; Carcinoma 256, Walker; Chlorambucil; Half-Life; Male; M

1988
Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines.
    Molecular pharmacology, 1987, Volume: 31, Issue:6

    Topics: Alkylating Agents; Animals; Carcinoma 256, Walker; Chlorambucil; Cytosol; Drug Resistance; Glutathio

1987
Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards.
    Cancer treatment reports, 1985, Volume: 69, Issue:6

    Topics: Animals; Carcinoma 256, Walker; Cell Line; Cells, Cultured; Chlorambucil; Drug Resistance; Glutathio

1985
Letter: Behavior of tumours in conditions of experimental magnesium deficiency.
    Lancet (London, England), 1974, Sep-28, Volume: 2, Issue:7883

    Topics: Animals; Carcinoma 256, Walker; Chlorambucil; Magnesium; Magnesium Deficiency; Radioisotopes; Rats

1974
Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo.
    Cancer research, 1973, Volume: 33, Issue:6

    Topics: Acrolein; Animals; Biological Assay; Carcinoma 256, Walker; Cell Survival; Chlorambucil; Cyclophosph

1973
Walker carcinosarcoma 256 in study of anticancer agents. I. Method for simultaneous assessment of therapeutic value and toxicity.
    Cancer research, 1966, Volume: 26, Issue:8 Pt 2

    Topics: Amines; Aniline Compounds; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chlorambucil; Naph

1966
[A method of primary selection of antitumor agents].
    Voprosy onkologii, 1971, Volume: 17, Issue:2

    Topics: Adenocarcinoma; Animals; Carcinoma 256, Walker; Chlorambucil; Cyclophosphamide; Melphalan; Mercaptop

1971
Growth inhibitory and haematological effects of alkylating agents and attempts at their modification to give greater selectivity of anti-tumour action.
    Acta geneticae medicae et gemellologiae, 1968, Volume: 17, Issue:1

    Topics: Alkylating Agents; Animals; Body Weight; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Chlor

1968